Skip to Content

  • Search

View Additional Section Content

A phase 2b, dose-ranging study to evaluate the efficacy and safety of MEDI-563 in adults with uncontrolled asthma

Principal Investigator(s)
Robert Anolik, M.D.

Clinical Trial Categories

  • Asthma
Contact
Research Center of Allergy and Asthma Specialists at 877-877-8839

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details